Lazard Asset Management Portfolio holdings
AUM
$72.7B
1-Year Return
14.89%
This Quarter Return
-1.32%
1 Year Return
+14.89%
3 Year Return
+61.14%
5 Year Return
+112.7%
10 Year Return
+262.42%
AUM
$65.1B
AUM Growth
-$3.23B
(-4.7%)
Cap. Flow
-$6.9B
Cap. Flow
% of AUM
-10.59%
Top 10 Holdings %
Top 10 Hldgs %
24.01%
Holding
2,655
New
236
Increased
958
Reduced
794
Closed
308
Top Buys
| 1 |
Apple
AAPL
|
$350M |
| 2 |
Qualcomm
QCOM
|
$280M |
| 3 |
Trane Technologies
TT
|
$206M |
| 4 |
Salesforce
CRM
|
$167M |
| 5 |
Equifax
EFX
|
$156M |
Top Sells
| 1 |
Amazon
AMZN
|
$510M |
| 2 |
UnitedHealth
UNH
|
$317M |
| 3 |
Norfolk Southern
NSC
|
$314M |
| 4 |
CVS Health
CVS
|
$269M |
| 5 |
Honeywell
HON
|
$232M |
Sector Composition
| 1 | Technology | 24.38% |
| 2 | Financials | 15.1% |
| 3 | Healthcare | 11.43% |
| 4 | Industrials | 11.07% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$21.6B
| – | – |
0
| – | -$24M |
|
227
AT&T
T
$212B
| $25.4M | 0.04% |
898,998
-170,886
| -16% | -$4.83M |
|
228
Verizon
VZ
$187B
| $24.9M | 0.04% |
549,124
-56,720
| -9% | -$2.57M |
|
229
Commerce Bancshares
CBSH
$8.08B
| $24.6M | 0.04% |
395,125
-10,846
| -3% | -$675K |
|
230
AXIS Capital
AXS
$7.62B
| $24.6M | 0.04% |
245,082
-38,104
| -13% | -$3.82M |
|
231
Vanguard Tax-Exempt Bond Index Fund
VTEB
$38.3B
| – | – |
0
| – | -$23.2M |
|
232
Becton Dickinson
BDX
$55.1B
| $24.3M | 0.04% |
106,065
+39,960
| +60% | +$9.15M |
|
233
AngloGold Ashanti
AU
$30.2B
| $24M | 0.04% |
647,880
-102,371
| -14% | -$3.8M |
|
234
Fortinet
FTNT
$60.4B
| $23.5M | 0.04% |
244,526
-41,890
| -15% | -$4.03M |
|
235
Copart
CPRT
$47B
| $23.4M | 0.04% |
414,374
+383,869
| +1,258% | +$21.7M |
|
236
Nu Holdings
NU
$71.2B
| $23.4M | 0.04% |
2,288,563
-1,901,655
| -45% | -$19.5M |
|
237
GMO US Quality ETF
QLTY
$2.43B
| $23.2M | 0.04% |
618,126
+134,450
| +28% | +$5.04M |
|
238
F5
FFIV
$18.1B
| $23.1M | 0.04% |
86,627
+18,321
| +27% | +$4.88M |
|
239
Elevance Health
ELV
$70.6B
| $23M | 0.04% |
52,902
+13,063
| +33% | +$5.68M |
|
240
Middleby
MIDD
$7.32B
| $22.8M | 0.04% |
150,106
-20,862
| -12% | -$3.17M |
|
|
GF
241
New Germany Fund
GF
$184M
| $22.5M | 0.03% |
2,297,497
+658,596
| +40% | +$6.46M |
|
242
IBM
IBM
$232B
| $22.5M | 0.03% |
90,455
-49,518
| -35% | -$12.3M |
|
243
Stevanato
STVN
$6.59B
| $22.3M | 0.03% |
1,092,303
-61,814
| -5% | -$1.26M |
|
244
Pfizer
PFE
$141B
| $22.3M | 0.03% |
879,443
+675,243
| +331% | +$17.1M |
|
245
Freeport-McMoran
FCX
$66.5B
| $21.9M | 0.03% |
579,268
+17,744
| +3% | +$672K |
|
246
Yum China
YUMC
$16.5B
| $21.7M | 0.03% |
416,003
+61,759
| +17% | +$3.21M |
|
247
iShares MSCI Emerging Markets ETF
EEM
$19.2B
| $21.6M | 0.03% |
494,277
-2,244,436
| -82% | -$98.1M |
|
|
248
CVS Health
CVS
$93.6B
| $21.5M | 0.03% |
317,000
-3,973,953
| -93% | -$269M |
|
249
SBA Communications
SBAC
$21.2B
| $21.3M | 0.03% |
96,810
+33,036
| +52% | +$7.27M |
|
250
Vaxcyte
PCVX
$4.29B
| $21.1M | 0.03% |
557,794
+71,030
| +15% | +$2.68M |
|